---
title: "YIXINTANG has completed the repurchase, spending a total of 150 million yuan to buy back 1.96% of its shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/230804507.md"
description: "According to the Zhitong Finance APP, YIXINTANG announced that the implementation of the share repurchase plan has been completed. As of March 5, 2025, the company has repurchased a total of 11.4759 million shares through centralized bidding, accounting for 1.96% of the company's current total share capital, with a total transaction amount of 150 million yuan (excluding transaction fees)"
datetime: "2025-03-06T09:55:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/230804507.md)
  - [en](https://longbridge.com/en/news/230804507.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/230804507.md)
generator: "portal-rs"
---

# YIXINTANG has completed the repurchase, spending a total of 150 million yuan to buy back 1.96% of its shares

According to the Zhitong Finance APP, YIXINTANG (002727.SZ) announced that the implementation of the share repurchase plan has been completed. As of March 5, 2025, the company has repurchased a total of 11.4759 million shares through centralized bidding, accounting for 1.96% of the company's current total share capital, with a total transaction amount of 150 million yuan (excluding transaction fees)

### Related Stocks

- [002727.CN](https://longbridge.com/en/quote/002727.CN.md)

## Related News & Research

- [Calian launches share buyback program for up to 994,301 shares](https://longbridge.com/en/news/297317418.md)
- [Freetrailer Begins Share Repurchase Programme](https://longbridge.com/en/news/297279271.md)
- [Senvest Capital launches buyback for up to 100,000 shares on TSX](https://longbridge.com/en/news/296914832.md)
- [Vistance Networks boosts share buyback program by $150 million](https://longbridge.com/en/news/297085381.md)
- [Qlife enters fully funded feasibility deal with global pharma company for Egoo Health biomarker application](https://longbridge.com/en/news/296995766.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**